ConsumerLab saw palmetto
This article was originally published in The Tan Sheet
Executive Summary
Seventeen of 22 saw palmetto supplements evaluated contain ingredients "similar to those known to work in clinical studies," online testing firm announces May 20. Two failing products were found to contain roughly half the amount of saw palmetto known to work, ConsumerLab.com notes, while one supplement contained "unusually high levels of sterols and specific fatty acids, suggesting the addition of undeclared oil in the product." NBTY, NOW Foods among firms with "passing" supplements. Review is second on saw palmetto supplements to be conducted by ConsumerLab; last test in 2000 passed eight of 13 products (1"The Tan Sheet" August 20, 2000, p. 6)...
You may also be interested in...
CR Saw Palmetto Review Produces Mixed Results; More Tests Upcoming
Only eight of 13 saw palmetto supplements tested by Consumer Reports contain an adequate amount of the extract, the magazine reports in its September issue.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.